Oslo, 15 October 2021, Ultimovacs ASA (the “Company”) refers to the announcement published on 12 October 2021 regarding the issuance of new shares in connection with the Company’s employee incentive program.
The share capital increase related to the share issue has been registered in the Norwegian Register of Business Enterprises, and the Company’s new share capital is NOK 3,206,176.10, divided into 32,061,761 shares, each with a par value of NOK 0.10.
For further information, please contact:
Jónas Einarsson, Chairman of the Board of Directors of Ultimovacs ASA
Email: je@radforsk.no
Phone: +47 480 96 355
Carlos de Sousa, CEO
Email: carlos.desousa@ultimovacs.com
Phone: +47 908 92507
Hans Vassgård Eid, CFO
Email: hans.eid@ultimovacs.com
Phone: +47 482 48632
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to…
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to…
Winter Park, Florida--(Newsfile Corp. - December 29, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a…
DaVita works with others in under-resourced communities to offer individualized health engagements, break down mistrust…
PONTE VEDRA, FL / ACCESS Newswire / December 29, 2025 / Every industry has its…
Contract Research Organization for the REGAL trial has informed the Company that 72 events have…